VolitionRx Ltd. Faces Delisting Concerns
Ticker: VNRX · Form: 8-K · Filed: Apr 23, 2026 · CIK: 0000093314
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
Related Tickers: VNRX
TL;DR
VNRX might be delisted, check filings for details.
AI Summary
VolitionRx Ltd. filed an 8-K on April 23, 2026, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The filing also includes other events and financial statements/exhibits.
Why It Matters
This filing indicates potential issues with VolitionRx Ltd.'s continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to investors.
Key Players & Entities
- VOLITIONRX LTD (company) — Filer
- 0000093314 (company) — CIK
- 0001477932-26-002472 (filing_id) — SEC Accession Number
- 2026-04-23 (date) — Filing Date
FAQ
What specific rule or standard has VolitionRx Ltd. failed to satisfy that led to this notice?
The filing does not specify the exact rule or standard that VolitionRx Ltd. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What are the potential consequences of this delisting notice for VolitionRx Ltd. shareholders?
A delisting could lead to increased trading volatility, reduced liquidity for shares, and a potential decrease in stock price, impacting shareholders.
Does the filing indicate any steps VolitionRx Ltd. is taking to address the listing issue?
The provided filing details do not explicitly state the steps VolitionRx Ltd. is taking to address the listing issue, beyond the general reporting of the notice.
When was this 8-K filing accepted by the SEC?
This 8-K filing was accepted by the SEC on April 23, 2026, at 08:45:52.
What other items are included in this 8-K filing besides the delisting notice?
This 8-K filing also includes Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 23, 2026 regarding VOLITIONRX LTD (VNRX).